UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951

Leukemia, 2015-11, Vol.29 (11), p.2154-2161

2015

Volltextzugriff (PDF)

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

Leukemia, 2010-12, Vol.24 (12), p.2023-2031

2010

Volltextzugriff (PDF)

CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2021-07, Vol.28 (5), p.411-416

2021

Volltextzugriff (PDF)

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials

Leukemia, 2018-01, Vol.32 (1), p.244-248

2018

Volltextzugriff (PDF)

Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology

Journal of clinical pharmacy and therapeutics, 2011-04, Vol.36 (2), p.152-160

2011

Volltextzugriff (PDF)

Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience

Leukemia, 2010-07, Vol.24 (7), p.1386-1388

2010

Volltextzugriff (PDF)

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Haematologica (Roma), 2014-07, Vol.99 (7), p.1220-1227

2014

Volltextzugriff (PDF)

Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL

Leukemia, 2003-10, Vol.17 (10), p.2056

2003

Volltextzugriff (PDF)

Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia

Leukemia, 2010-01, Vol.24 (1), p.205-209

2010

Volltextzugriff (PDF)

Value of High-Dose Cytarabine During Interval Therapy of a Berlin-Frankfurt-Munster–Based Protocol in Increased-Risk Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial

Journal of clinical oncology, 2001-04, Vol.19 (7), p.1935-1942

2001

Volltextzugriff (PDF)

Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial

European journal of cancer (1990), 2008-04, Vol.44 (6), p.840-846

2008

Volltextzugriff (PDF)

Hodgkin disease and autoimmunity in children: 11 case reports

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2011-04, Vol.18 (4), p.376-382

2011

Volltextzugriff (PDF)

High WT1 Expression After Induction Therapy Predicts High Risk of Relapse and Death in Pediatric Acute Myeloid Leukemia

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1507-1515

2006

Volltextzugriff (PDF)

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG

Leukemia, 2005-05, Vol.19 (5), p.721-726

2005

Volltextzugriff (PDF)

Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis

Archives of disease in childhood, 2014-10, Vol.99 (10), p.A142

2014

Volltextzugriff (PDF)

PS-089Which Decision Rules Meet Methodological Standards In Children With Febrile Neutropenia? Results Of A Systematic Review And Analysis

Archives of disease in childhood, 2014-10, Vol.99 (Suppl 2), p.A142-A143

2014

Volltextzugriff (PDF)

PS-089 Which Decision Rules Meet Methodological Standards In Children With Febrile Neutropenia? Results Of A Systematic Review And Analysis

Archives of disease in childhood, 2014-10, Vol.99 (Suppl 2), p.A142-A143

2014

Volltextzugriff (PDF)

Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study

Haematologica (Roma), 2015-06, Vol.100 (6), p.810-817

2015

Volltextzugriff (PDF)

Maladie de Hodgkin et auto-immunité chez l’enfant : à propos de 11 observations

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2011-04, Vol.18 (4), p.376-382

2011

Volltextzugriff (PDF)

Cutaneous Involvement in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Pediatrics (Evanston), 1997-07, Vol.100 (1), p.60-64

1997

Volltextzugriff (PDF)

A Case of Adrenal Haemorrhage after Minor Trauma in a Young Child: Think of Neuroblastoma

European journal of pediatric surgery, 2006-10, Vol.16 (5), p.365-368

2006

Volltextzugriff (PDF)

Severe chronic primary neutropenia in adults: report on a series of 108 patients

Blood, 2015-10, Vol.126 (14), p.1643-1650

2015

Volltextzugriff (PDF)

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study

British journal of haematology, 2008-06, Vol.141 (6), p.840-847

2008

Volltextzugriff (PDF)

CO-35 – Couverture vaccinale des enfants traités par biothérapie pour une arthrite juvénile idiopathique au CHRU de Lille

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2015-05, Vol.22 (5), p.219-219

2015

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(98)
Französisch
(50)

Erscheinungsjahr

n.n

Thema

Humans
(79)
Science & Technology
(74)
Life Sciences & Biomedicine
(68)
Male
(65)
Female
(57)
Child
(51)
Child, Preschool
(44)
Biological And Medical Sciences
(40)
Infant
(39)
Adolescent
(37)
Medical Sciences
(34)
Hematology
(25)
Oncology
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Pediatrics
(18)
Treatment Outcome
(17)
Infant, Newborn
(15)
Pharmacology. Drug Treatments
(15)
Adult
(14)
Hematologic And Hematopoietic Diseases
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials

Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology

Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL

Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia

Value of High-Dose Cytarabine During Interval Therapy of a Berlin-Frankfurt-Munster–Based Protocol in Increased-Risk Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial

Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial

Hodgkin disease and autoimmunity in children: 11 case reports

High WT1 Expression After Induction Therapy Predicts High Risk of Relapse and Death in Pediatric Acute Myeloid Leukemia

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG

Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis

PS-089Which Decision Rules Meet Methodological Standards In Children With Febrile Neutropenia? Results Of A Systematic Review And Analysis

PS-089 Which Decision Rules Meet Methodological Standards In Children With Febrile Neutropenia? Results Of A Systematic Review And Analysis

Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study

Maladie de Hodgkin et auto-immunité chez l’enfant : à propos de 11 observations

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

Cutaneous Involvement in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

A Case of Adrenal Haemorrhage after Minor Trauma in a Young Child: Think of Neuroblastoma

Severe chronic primary neutropenia in adults: report on a series of 108 patients

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study

CO-35 – Couverture vaccinale des enfants traités par biothérapie pour une arthrite juvénile idiopathique au CHRU de Lille

Suchergebnisse filtern